Last reviewed: June 6, 2026
Last updated: June 6, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.
GLP-1 receptor agonists have transformed weight management by reducing hunger and improving blood sugar control. Clinical trials show that patients using semaglutide lose an average of 14–18 pounds in the first three months, with cumulative weight loss reaching 35–50+ pounds by month twelve. Your actual results depend on your starting weight, metabolism, genetics, and commitment to healthy habits.
Average Weight Loss on GLP-1 Therapy: Clinical Evidence
The STEP clinical trial program demonstrated that patients on semaglutide 2.4 mg achieved mean weight loss of 14.9% of body weight over 68 weeks—significantly more than the 2.4% loss observed in the placebo group. For a 250-pound person, this translates to approximately 37 pounds of weight reduction. Results were consistent across age groups and baseline BMI categories, suggesting broad effectiveness across diverse patient populations.
Tirzepatide, a dual GLP-1 and GIP receptor agonist, showed even greater results in the SURMOUNT trials, with patients losing up to 22.5% of body weight at the highest dose. The average timeline for noticeable weight loss is 4–6 weeks, though some patients report appetite suppression within days of starting therapy. Weight loss typically continues throughout the year of treatment, with stabilization occurring around month 10–12.
How Your Genetics Influence GLP-1 Weight Loss Outcomes
Your response to GLP-1 medications is shaped by genetic variations in key appetite and metabolism pathways. PlexusDx Precision Peptide Genetic Test maps 14 metabolic pathways and 150+ genetic insights, including variants in GLP1R, GIPR, FTO, and MC4R genes that predict how your body will respond to semaglutide or tirzepatide. Patients with specific FTO rs9939609 or MC4R rs17782313 variants may experience different baseline metabolic rates and appetite regulation, affecting the pace and magnitude of weight loss.
Understanding your peptide genetic profile allows PlexusDx clinicians to match you with the compound and starting dose most likely to succeed for your body. A patient with a favorable GLP1R rs6923761 profile might see rapid response, while another patient with different genetics may benefit from a dual-therapy approach like GLP-Squared (combined semaglutide and tirzepatide). This personalization explains why weight loss timelines and final outcomes vary so widely across individuals, even at identical doses.
Timeline: When You'll See Weight Loss Results
Most patients notice reduced appetite and early weight loss within the first 2–4 weeks of starting semaglutide or tirzepatide, though the scale may not reflect this immediately due to fluid shifts and metabolic adjustment. By week 8–12, cumulative weight loss typically becomes visible and measurable. The rate slows somewhat after the initial rapid phase but continues steadily through month 6–12 as your body reaches a new metabolic baseline.
Consistency matters more than perfection: weekly injections, adherence to your protocol, and steady lifestyle habits compound over time. PlexusDx patients who combine medication with modest calorie awareness and movement generally achieve superior outcomes compared to medication alone. Plateau periods are normal and temporary—adjusting injection timing, reviewing dietary choices, or optimizing your protocol with PlexusDx clinicians often restarts progress.
Factors That Affect Your Individual Weight Loss Results
Your starting weight, age, existing medications, metabolic health, and sleep quality all influence how much weight you'll lose and how quickly. Patients with insulin resistance or prediabetes often see faster initial results because GLP-1s improve glucose handling and reduce metabolic stress. Conversely, patients on certain medications (like some antipsychotics) or with very low baseline activity levels may need longer to see equivalent results.
PlexusDx recommends pairing medication with sustainable nutrition and movement habits for best outcomes. You don't need extreme restriction—appetite suppression from semaglutide makes modest calorie reduction feel natural rather than forced. Hydration, sleep consistency, stress management, and strength training amplify weight loss and help preserve lean muscle mass, protecting your metabolism as you lose weight. PlexusDx clinicians can discuss which lifestyle adjustments align with your schedule and preferences.
How Your Genetics Influence GLP-1 Response
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.
Frequently Asked Questions
Can I expect to lose 50 pounds on semaglutide?
Yes, many patients lose 40–60+ pounds over one year, though results range from 15–50+ pounds depending on starting weight, genetics, and lifestyle factors. A 300-pound patient losing 45 pounds (15% body weight) is a realistic expectation for one year of consistent semaglutide therapy. Your Precision Peptide Genetic Test can help predict which individuals are likely to achieve the fastest, most dramatic results.
How long does it take to lose 20 pounds on GLP-1 medication?
Most patients achieve 20-pound weight loss between months 3–5 of treatment, though timing varies. STEP trial data showed average 14-pound loss by 12 weeks and continued steady decline thereafter. Faster responders, especially those with favorable genetic profiles, may hit 20 pounds by month 2–3.
Is PlexusDx semaglutide expensive compared to other weight loss medications?
PlexusDx compounded semaglutide starts at $149 per month with no insurance required, no membership fees, and HSA/FSA eligibility—making it significantly more affordable than brand-name alternatives. Your dose may need to go up, but your price won't, keeping costs predictable throughout treatment.
Will I regain the weight once I stop taking GLP-1 medication?
Some weight regain occurs in most patients after stopping, though the amount varies. Clinical data suggests about 50% of lost weight returns within one year after discontinuation, but ongoing lifestyle habits acquired during treatment often persist. Many patients continue long-term for sustained weight management, similar to treating high blood pressure or diabetes.
How does the PlexusDx Precision Peptide Genetic Test help predict my weight loss?
PlexusDx maps 14 metabolic pathways and 150+ genetic insights, including GLP1R, GIPR, FTO, and MC4R variants that influence appetite suppression, insulin sensitivity, and baseline metabolism. These genetic markers help predict whether you'll respond rapidly to semaglutide, whether tirzepatide may be more effective, or which dual-therapy approach suits your biology best. The test costs $99 as an add-on after your first month.
Related Reading
Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.
Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
Understanding How GLP-1 Medication Works for Weight Loss and Diabetes Management
What Happens If You Miss a Semaglutide Injection?